Listen to the article
Rectal Cancer Deaths Rising Alarmingly Among Young Adults
Rectal cancer mortality rates are increasing two to three times faster than colon cancer deaths among Americans aged 20 to 44, according to new research that highlights a growing health crisis affecting younger generations.
A study to be presented at Digestive Disease Week 2026 in Chicago reveals that this trend is particularly concerning for older millennials, with projections showing rectal cancer mortality will continue to escalate through 2035 for those between 35 and 44 years old.
“Colorectal cancer is no longer considered predominantly a disease of older adults,” explained lead author Mythili Menon Pathiyil, a gastroenterology fellow at SUNY Upstate Medical University. “Rectal cancer, especially, is becoming a growing problem in younger individuals.”
The research team analyzed Centers for Disease Control and Prevention (CDC) death records spanning 1999 to 2023. Using machine learning models to forecast future trends, they discovered the mortality gap between rectal and colon cancers is widening across all demographics.
Hispanic adults and residents of Western states have experienced the steepest increases in rectal cancer deaths, according to the findings. This regional and demographic variation suggests potential environmental or lifestyle factors that may contribute to the disparity.
A particularly troubling aspect of this trend is the significant diagnostic delay often experienced by younger patients. While older adults typically begin treatment within a month of symptoms appearing, young adults face an average seven-month delay before receiving care.
Dr. Rachel Gordon, a New York-based colorectal and general surgeon at Episcopal Health Services, noted that young people are increasingly being diagnosed with rectal cancers at more advanced, aggressive stages. “We’re seeing a combination of lifestyle and environmental exposures, including diet and changes in the gut microbiome, potentially playing a role,” said Gordon, who was not involved in the study.
Medical experts point to a concerning pattern where primary care providers often dismiss warning signs in younger patients. Symptoms such as rectal bleeding or changes in bowel habits are frequently attributed to benign conditions like hemorrhoids, leading to critical delays in diagnosis and treatment.
“If something doesn’t feel right, or if you experience symptoms such as rectal bleeding, persistent changes in bowel habits, narrow stools, a feeling of incomplete bowel emptying, abdominal pain, unexplained weight loss or fatigue, it’s important to see your doctor promptly,” Gordon advised.
The findings come amid increasing concern about colorectal cancer rates in younger populations generally. In recent years, medical organizations have lowered the recommended age for beginning colorectal cancer screenings from 50 to 45 for average-risk individuals. However, this research suggests that current screening strategies may need further evaluation to address the specific rise in rectal cancer.
Public health experts point to several potential factors behind the increase, including dietary changes, sedentary lifestyles, increased obesity rates, and alterations in gut microbiome composition. The Western diet, high in processed foods and low in fiber, has previously been linked to increased colorectal cancer risk.
The study’s findings underscore the importance of raising awareness about colorectal cancer symptoms among both the public and medical professionals. Early detection remains critical for improving survival rates, particularly for rectal cancer where treatment options and outcomes may differ from colon cancer.
“Our study shows that rectal cancer is driving much of the increase in colorectal cancers,” Pathiyil emphasized. “It’s likely to worsen over time if we don’t change what we are doing right now.”
The research highlights the urgent need for targeted education, improved diagnostic protocols, and potentially earlier screening for high-risk individuals to address this growing health concern among younger Americans.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.


8 Comments
This is a worrying development that challenges the traditional view of colorectal cancer as a disease primarily affecting older adults. The acceleration of rectal cancer mortality among younger generations is an urgent public health concern that requires a multifaceted response.
This is a concerning development that warrants close attention from the medical community and policymakers. The disproportionate impact on younger adults is particularly alarming and underscores the need for a deeper dive into the underlying factors.
The study’s findings that rectal cancer mortality is increasing two to three times faster than colon cancer in the 20-44 age group is really troubling. I hope this prompts further research to uncover the reasons behind this disturbing shift.
Yes, I agree. Understanding the drivers of this trend is key to developing effective prevention and intervention strategies. Early screening and education efforts could play a critical role in addressing this emerging public health issue.
This is concerning news about the rising rates of rectal cancer mortality among young adults. It’s crucial that we understand the underlying causes and find ways to address this alarming trend through early detection and improved treatment options.
The study’s findings underscore the need for increased awareness, screening, and research into the factors driving the rise in rectal cancer mortality among younger adults. Early intervention and tailored prevention strategies could make a significant difference in addressing this emerging health crisis.
The widening mortality gap between rectal and colon cancers, especially among Hispanic adults and residents of Western states, is a sobering statistic. I hope this study spurs further research and targeted public health initiatives to address these disparities.
Agreed. Identifying and addressing the root causes of these troubling trends, particularly the demographic differences, will be crucial to ensuring equitable access to early detection and effective treatment options.